Lived experiences of closeness to a person using Anabolic androgenic steroids a next of kin perspectiveShow others and affiliations
2023 (English)In: International Journal of Qualitative Studies on Health and Well-being, ISSN 1748-2623, E-ISSN 1748-2631, Vol. 19, no 1Article in journal (Refereed) Published
Abstract [en]
Purpose: Anabolic androgenic steroids (AAS) are used for their aesthetic and performance-enhancing effects and are associated with physical and psychological side effects. Behavioural changes/side effects as mood swings, aggressiveness, depression, potency problems, anxiety, and emotional coldness have been reported by next of kin to people using AAS.
Methods: This phenomenological study is based on the reflective lifeworld research approach. Interviews were conducted with twelve next of kin about their experiences of living close to persons using AAS.
Results: Next of kin to persons using AAS are particularly vulnerable because they experience little opportunity to influence their situation. Their given and safe context is lost, and their lives are circumscribed by feelings of insecurity, fear, powerlessness, and grief. Feelings of loneliness develop when their problems are not noticed by others and support is lacking from family and society.
Conclusions: Our research adds important knowledge on how the use of AAS affects next of kin. Understanding is required to approach the lifeworld of next of kin with flexibility and empathy in their difficulties and vulnerability. Healthcare professionals and other concerned professions need to be aware of next of kin existential needs to be able to meet and support them in their life situation.
Place, publisher, year, edition, pages
2023. Vol. 19, no 1
Keywords [en]
AAS, Anabolic androgenic steroids, caring science perspective, next of kin, phenomenology, reflective lifeworld research, relative, use
National Category
Nursing
Research subject
The Human Perspective in Care; The Human Perspective in Care
Identifiers
URN: urn:nbn:se:hb:diva-31074DOI: 10.1080/17482631.2023.2292826ISI: 001126515300001Scopus ID: 2-s2.0-85179648505OAI: oai:DiVA.org:hb-31074DiVA, id: diva2:1822361
2023-12-222023-12-222024-01-12Bibliographically approved